S4 TO 108 NCATS GENE THERAPY VECTOR
$2,338,050N02FY2023ODNIH
Medical Science & Computing, Llc, Rockville MD
Investigators
Abstract
Produce and deliver a research grade gene therapy vector for a potential lead candidate for hereditary methylmalonic acidemias using AAV9 platform-based gene therapy vector platform.
View original record on NIH RePORTER →